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Introduction
Genotoxic stress, such as exposure to UV light, induces the ac-
cumulation of different types of DNA lesions and a wide range 
of cellular responses (Stokes and Comb, 2008). To maintain cell 
viability, replication forks that encounter damaged DNA must 
efficiently bypass these lesions to complete replication of the 
genome in a timely manner during S phase. DNA synthesis 
across damaged DNA is achieved by specialized DNA polymer-
ases that incorporate nucleotides opposite to damaged bases in 
a process known as trans-lesion synthesis (TLS; Lehmann et al., 
2007).  However,  overuse  of  TLS  polymerases  can  increase   
mutagenesis because of their highly accommodating active sites 
and lack of proofreading activity (Waters et al., 2009). The re-
cruitment of TLS polymerases for lesion bypass requires the 
monoubiquitination of proliferating cell nuclear antigen (PCNA; 
Kannouche et al., 2004; Watanabe et al., 2004; Bienko et al., 
2005; Garg and Burgers, 2005; Plosky et al., 2006). Regulatory 
factors that control the level of PCNA ubiquitination, such as 
ubiquitin ligases and proteases, are important to promote an op-
timal balance between TLS-associated cell survival and TLS-
associated mutagenesis (Prives and Gottifredi, 2008). This has 
been previously described in a series of elegant work that sug-
gest the recruitment of Pol- (a member of the Y family of TLS 
polymerases) to UV lesions by the Rad18-dependent mono-
ubiquitination  of  PCNA  (Kannouche  et  al.,  2004; Watanabe   
et al., 2004). The model predicts that the blockage of replicative 
polymerases activates PCNA monoubiquitination at replication-
stalled sites (Hoege et al., 2002; Friedberg et al., 2005). This 
event in turn promotes the recruitment of TLS polymerases to 
bypass the lesion and allow continuation of DNA replication. It 
has been suggested that the switch back from TLS to normal 
processive polymerases is regulated by ubiquitin-specific prote-
ase 1 (USP1), the deubiquitinating enzyme for PCNA (Huang 
and D’Andrea, 2006; Huang et al., 2006; Ulrich, 2006).
However, recent studies have shown that PCNA mono-
ubiquitination can occur outside of S phase both in mammalian 
and yeast systems (Frampton et al., 2006; Soria et al., 2006, 2009; 
Daigaku et al., 2010; Karras and Jentsch, 2010; Ogi et al., 2010). 
Moreover, Pol- and other TLS polymerases can be recruited to 
sites of UV lesions in quiescent or noncycling cells, which is in 
line with possible roles in gap-filling of DNA damage tracks left 
behind  the  replication  forks  (Lehmann  and  Fuchs,  2006; 
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deoxyribonucleic acid (DNA) damage, suggesting that it 
may play a previously unrecognized role in maintaining 
genomic stability. The ubiquitin-specific protease 1 (USP1) 
is a known critical regulator of DNA repair and genomic 
stability. In this paper, we report that USP1 was degraded 
in G1 via APC/C
Cdh1. USP1 levels were kept low in G1 to 
provide a permissive condition for inducing proliferating 
cell nuclear antigen (PCNA) monoubiquitination in re-
sponse to ultraviolet (UV) damage before DNA replica-
tion. Importantly, expression of a USP1 mutant that cannot 
be degraded via APC/C
Cdh1 inhibited PCNA monoubiq-
uitination during G1, likely compromising the recruitment 
of trans-lesion synthesis polymerase to UV repair sites. 
Thus, we propose a role for APC/C
Cdh1 in modulating the 
status of PCNA monoubiquitination and UV DNA repair 
before S phase entry.
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in check before S phase entry. Low levels of USP1 enable robust 
UV-induced  PCNA  monoubiquitination  during  G1,  which  is 
likely to allow the recruitment of TLS polymerases to UV   
lesions. These findings suggest that APC/C
Cdh1 plays a direct role in 
modulating the DNA repair choice in G1 and further solidify the 
link between cell cycle regulation and DNA repair.
Results and discussion
USP1 levels are low during the G1 phase  
of the cell cycle
To investigate whether USP1 activity is cell cycle regulated, we 
examined whether USP1 protein levels fluctuate in cells pro-
gressing through the cell cycle. We synchronized both U2OS 
and HeLa cells in prometaphase and then let them progress 
from mitosis into the next cell cycle. We found that USP1 levels 
are low during G1 and high during S phase (Fig. 1, A and B). 
We also observed low levels of USP1 in serum-starved and   
G1 T98G cells, similar to other proteins known to be degraded in 
G0/G1, such as Plk1 and cyclin A (Fig. 1 C). USP1 DUB activ-
ity depends on the interaction with its catalytic cofactor WDR48 
(also called UAF1; Cohn et al., 2007). In contrast to USP1, 
WDR48 levels did not change throughout the cell cycle (Fig. 1 B 
and not depicted).
APC/C
Cdh1 regulates USP1 levels in G1
The down-regulation of USP1 in the G1 phase of the cell cycle 
led us to ask whether a ubiquitin ligase may be responsible for 
the degradation of USP1. As the APC/C
Cdh1 complex is critical 
for promoting the degradation of cell cycle regulators in G1, we 
tested whether this ubiquitin ligase also regulates the G1 levels 
of USP1. To this end, we silenced Cdh1 expression in both syn-
chronized T98G and synchronized U2OS cells using well-
established siRNA oligonucleotides (Bashir et al., 2004). We 
found that USP1 accumulated in both asynchronous and G1 cells 
depleted of Cdh1 (Fig. 2, A and B). This accumulation ap-
pears to be caused by USP1 stabilization, as shown by measur-
ing USP1 half-life (Fig. 2 C). As expected (APC/C
Cdh1 is inactive 
during prometaphase), the accumulation of USP1 after Cdh1   
silencing was not as prominent in M phase cells (Fig. 2 B). 
Similarly, upon Cdh1 silencing, Plk1, a known Cdh1 substrate, 
was also more accumulated in asynchronous and G1 cells than in   
M phase synchronized cells (Fig. 2 B).
Next, we determined whether USP1 DUB activity is func-
tional during the G1 phase. To this end, we measured the ability 
of USP1 to react with a chemically modified ubiquitin suicide 
substrate probe (ubiquitin vinyl sulfone [UbVS]; Borodovsky   
et al., 2002). We found that G1-stabilized USP1 was still cata-
lytically active (Fig. 2 D). This suggests that USP1 proteolysis 
is likely a critical mechanism to inhibit USP1 activity during the 
G1 phase. Thus, we predict that a stable mutant of USP1 that 
could not be targeted by APC/C
Cdh1 during G1 would still inter-
act with WDR48 (which is expressed in G1 as shown in Fig. 1 B) 
and deconjugate specific monoubiquitinated substrates.
To ensure that the Cdh1 knockdown effect on USP1 sta-
bility was direct, we addressed whether Cdh1 could interact with 
USP1 in vivo. We found that both exogenously and endogenously 
Lopes et al., 2006). As such, the gap-filling pathway is likely 
not limited to S phase but also occurs in G0, G1, and G2/M 
phases.  PCNA  monoubiquitination  and  TLS  polymerase  re-
cruitment to UV lesions have also been recently implicated in 
nucleotide excision repair (NER), a DNA repair process that 
can take place outside of S phase (Ogi et al., 2010). It is cur-
rently unclear whether specific cell cycle phases, such as G1 or 
S phase, can dictate the mechanism of how the cell responds to 
UV-mediated DNA damage through the activation of PCNA 
monoubiquitination and subsequent DNA repair.
The anaphase-promoting complex/cyclosome (APC/C) is 
a multisubunit ubiquitin ligase that targets many key cell cycle 
regulators for proteolysis (Qiao et al., 2010). The activation of 
APC/C is dependent on two WD-40 repeat domain–containing 
proteins,  Cdc20  and  Cdh1.  Whereas  APC/C
Cdc20  principally 
regulates mitotic progression, APC/C
Cdh1 shows a broad spec-
trum of G1-specific substrates, including proteins that function 
beyond cell cycle control (Skaar and Pagano, 2008; Qiao et al., 
2010). Previous studies have shown that Cdh1 knockout or de-
pletion in mammalian cells can cause genomic instability, but 
the precise cause of this instability is unclear (Engelbert et al., 
2008; García-Higuera et al., 2008). Recently, however, the sta-
bility of several proteins involved in the DNA damage check-
point  response  and  DNA  repair,  such  as  Claspin,  Rad17, 
thymidine kinase 1, and the ribonucleotide reductase subunit 
RRM2, has been shown to be regulated by APC/C
Cdh1 (Chabes 
et al., 2003; Ke et al., 2005; Bassermann et al., 2008; Gao et al., 
2009; Zhang et al., 2010). Moreover, although APC/C
Cdh1 is   
active only at the very end of mitosis and during G1, it is reacti-
vated in G2 in response to DNA damage to target the mitotic 
kinase Plk1 for proteasomal degradation (Bassermann et al., 
2008). It is likely that more Cdh1 substrates will be identified 
with roles in the DNA damage response (DDR) pathways, fur-
ther underscoring the relevance and importance of APC/C in 
maintaining cellular genomic integrity.
In  humans,  protein  deubiquitination  is  controlled  by  a 
family of nearly 100 deubiquitinases (DUBs), but the function 
of many of these ubiquitin proteases is unknown (Nijman et al., 
2005b; Reyes-Turcu et al., 2009). The majority of DUBs are 
cysteine proteases that cleave ubiquitin from specific mono- 
and polyubiquitinated substrates or from linear ubiquitin poly-
peptides. The DUB USP1 is a critical regulator of genomic 
stability in mammalian cells (Kim et al., 2009). USP1 has been 
shown to regulate the monoubiquitination levels of three protein 
substrates involved in DNA repair: FANCD2 and FANCI (the 
Fanconi anemia [FA] effector proteins involved in DNA cross-
link repair) and PCNA (the DNA replication processivity factor 
whose function is important for the recruitment of specialized 
TLS polymerases to sites of UV DNA lesions; Nijman et al., 
2005a; Huang et al., 2006; Sims et al., 2007; Smogorzewska   
et al., 2007). However, it is unclear how USP1 negatively regu-
lates the monoubiquitination of substrates involved in two dis-
tinct DDR pathways.
In this study, we explore whether the control of USP1 lev-
els during cell cycle progression modulates the cellular response 
to UV DNA damage. We show that during G1, USP1 is targeted 
for degradation by APC/C
Cdh1 to ensure that USP1 levels are kept 179 USP1 proteolysis by APC/C
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Figure  1.  USP1  levels  are  low  during  the  G1  phase  of  the  cell  cycle.  
(A and B) HeLa (A) and U2OS (B) cells were synchronized in M phase by 
treating cells with nocodazole (Noc) for 16 h, washed, released, and col-
lected for the indicated time points. (C) T98G human glioblastoma cells were 
synchronized in G0/G1 by serum deprivation for 72 h and then refed with 
serum and harvested at the indicated time points. (A–C) Western blot analy-
ses were performed and probed with the indicated antibodies. Separate 
samples were also collected, fixed, and stained with PI for FACS analysis 
according to procedures outlined in the Materials and methods section.
Characterization of a USP1 mutant that 
cannot be degraded via APC/C
Cdh1
To search for a USP1 mutant that is stable in G1, we attempted to 
map  the  degradation  motif  (degron)  in  USP1. APC/C
Cdh1- 
mediated degradation typically requires the RXXL degron 
(known as destruction box or D box) in its target proteins (Glotzer 
et al., 1991). Although human USP1 contains three putative D box 
motifs and a KEN box (Fig. S1; Pfleger and Kirschner, 2000;   
Littlepage and Ruderman, 2002; Reis et al., 2006), their muta-
tion, singly or in combination, had no appreciable effect on USP1 
stability in G1 (not depicted). Thus, we suspected that USP1 pos-
sesses a noncanonical degron, which is similar to those found in 
Aurora A (Littlepage and Ruderman, 2002), Cdc20 (Reis et al., 
2006), or Claspin (Bassermann et al., 2008). To map the USP1 
degron, we generated a series of N- and C-terminal deletion mu-
tants (Fig. 3 A) and tested them for their ability to resist degrada-
tion in response to Cdh1 overexpression. We found that a region 
surrounding amino acids 307–330 of human USP1 is required for 
Cdh1-dependent degradation of USP1 (Fig. 3 B). Accordingly, a 
near full-length USP1 construct containing an internal deletion   
of 295–342 amino acids was stable in U2OS cells progressing 
through G1 (Fig. 3 C), whereas wild-type USP1, a USP1 (C90S) 
mutant (which is catalytic inactive), or the USP1 (GG670/671AA) 
diglycine mutant (which is unable to cleave itself) was not   
(Fig. 3 D). These results show that the catalytic and autocleavage 
activities of USP1 are not necessary for USP1 to be targeted for 
degradation by APC/C
Cdh1 during G1. This strongly suggests that 
the mechanism for degrading USP1 in G1 is completely different 
from the UV-initiated autocleavage and degradation of USP1 
during S phase, as the proteolysis of USP1 during G1 is indepen-
dent of its own catalytic activity (Huang et al., 2006).
We also generated a double USP1 mutant that contained 
both the 295–342 deletion and the GG670/671AA mutation, 
which was also resistant to proteolysis by APC/C
Cdh1 during G1 
(Fig. 3 E). To further support that USP1 is ubiquitinated via 
APC/C
Cdh1, we reconstituted the ubiquitination of USP1 in vitro. 
USP1 was efficiently ubiquitinated only when Cdh1 was present 
and  a  specific  E2  combination  was  used  (see  Materials  and 
methods section; Figs. 3 F and S2). Under our conditions, it is 
unclear why UBCH10-UBCH5 (Aristarkhov et al., 1996; King 
et al., 1996; Yu et al., 1996) works better than the canonical   
E2 pair UBCH10-UBE2S (Garnett et al., 2009; Williamson et al., 
2009; Wu et al., 2010) in promoting USP1 polyubiquitination. 
Interestingly, both UBCH10 and UBE2S are also degraded in 
G1 by APC/C
Cdh1, suggesting that other E2 enzymes may be re-
sponsible for ubiquitinating G1 versus M phase substrates of 
APC/C (Williamson et al., 2009). Importantly, Cdh1-dependent 
ubiquitination was not observed in the USP1 degron mutant 
(Fig. 3 G). Unexpectedly, the degron mutant was still capable of 
binding to Cdh1 in vitro, suggesting that the degron region may 
be more critical for promoting efficient APC/C
Cdh1-dependent 
ubiquitination of USP1 (Fig. S3). We have not ruled out the pos-
sibility of multiple Cdh1 binding sites on USP1 that may con-
tribute to its direct association with the APC/C
Cdh1 complex. 
Nevertheless, experiments in cell systems and in vitro show that 
Cdh1 promotes the ubiquitination and subsequent degradation 
of USP1 in a manner dependent on its degron region.
expressed USP1 can interact with members of the APC/C
Cdh1 com-
plex (Fig. 2, E–G). In T98G cells that are accumulating in G0/G1 
(serum starvation time course), we also show that endogenous 
USP1 can interact with Cdh1 before its degradation (Fig. 2 G).JCB • VOLUME 194 • NUMBER 2 • 2011   180
Figure 2.  Cdh1 depletion stabilizes USP1 during the G1 phase of the cell cycle. (A) T98G cells were transfected for 48 h with a control (Ctrl) siRNA (All-
Stars Negative; QIAGEN) or Cdh1 siRNA. Cells were serum starved in culture media containing 0.05% FBS for 24 h to arrest them in G0/G1. 0 indicates 
cells grown in regular media. (B) U2OS cells were transfected with the indicated siRNAs, synchronized in M phase (M) by incubating with nocodazole for 
16 h, washed, and released in fresh media for 3 h for G1 phase (G1). Separate samples were collected for FACS. (C) U2OS cells were transfected with 
the indicated siRNAs and treated for the indicated time points with cycloheximide (CHX) to inhibit protein synthesis. (D) U2OS cells were transfected with 
the indicated siRNAs and synchronized in G1 as in B. Samples were collected and lysed according to protocols described for the UbVS DUB activity assay 
(see Materials and methods). Higher shift in the USP1 protein band indicates active USP1 (covalently modified USP1 by HA-UbVS). (E) Expression constructs 
were cotransfected in U2OS cells and treated for 6 h with 10 µM of the proteasome inhibitor MG132 before termination. Samples were lysed and collected 
for immunoprecipitation (IP) or loaded for input. (F) U2OS cells were transfected with Myc-USP1 wild type (WT) for 48 h and treated with MG132 as in E.   
Samples were lysed and collected for immunoprecipitation. *, heavy chain band. (G) T98G cells were serum starved as in A for the indicated times. 
Samples were lysed and collected for immunoprecipitation and input (10%) and probed with the indicated antibodies for Western blot analysis.181 USP1 proteolysis by APC/C
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Figure 3.  Identification of a USP1 mutant that cannot be degraded via APC/C
Cdh1. (A) A schematic diagram of critical USP1 domains and Myc-USP1   
expression constructs generated for testing of their stability when coexpressed with FLAG-Cdh1. +, degradation of Myc-USP1; , stabilization of Myc-USP1; 
GG, diglycine residue for the USP1 autocleavage site; red x’s, deletion or point mutations of the region. (B) U2OS cells were transiently transfected with 
Myc-USP1 and/or Flag-Cdh1 constructs in the presence or absence of MG132 (3 h). IB, immunoblot. (C) U2OS cells were transfected with Myc-USP1 wild JCB • VOLUME 194 • NUMBER 2 • 2011   182
type (WT) or the 295–342 deletion (295–342 del) mutant and synchronized in M phase with nocodazole (Noc) for 16 h (0 h) and/or released into G1 (3 h   
after nocodazole release). As, asynchronous. (D) U2OS cells were transfected with Myc-USP1 wild type, C90S, or GG670/671AA and synchronized 
in M phase or G1 as in C. (E) U2OS cells were transfected with Myc-USP1 wild type, GG670/671AA, 295–342 deletion, or GG670/671AA plus the 
295–342 deletion mutant, synchronized, released into G1 (3 h after nocodazole release), and treated with cycloheximide (CHX) for 1 h (1) or not (0).   
(F) In vitro ubiquitination assay of Myc-USP1 wild type in the presence or absence of HA-Cdh1. Reactions were performed as described in the Materials and 
methods section. (G) In vitro ubiquitination assay of Myc-USP1 wild type, C90S, and GG670/671AA plus the 295–342 deletion mutant in the presence 
or absence of HA-Cdh1. Rxn, reaction.
 
D and E). Thus, from our study, we provide a model suggesting 
that degradation of USP1 by the APC/C
Cdh1 during G1 is critical 
for cells to properly recruit TLS polymerases for UV-mediated 
DNA gap repair (Fig. 4 F).
Conclusion
Proteolytic control of cell cycle regulators by the APC/C
Cdh1 
ubiquitin ligase complex is responsible not only for a stable   
G1 phase after mitotic exit but also for allowing accurate prepara-
tion for DNA replication in the following S phase (Nakayama 
and Nakayama, 2006). It is known that some of these APC/C
Cdh1 
target proteins are frequently up-regulated in tumor cells, and 
inactivation of human and mouse Cdh1 interferes with genome 
integrity (Engelbert et al., 2008; García-Higuera et al., 2008). 
However, it is still unclear what protein targets of APC/C
Cdh1 are 
critical for maintaining genomic stability in human cells. Here, we 
show that USP1 can be targeted for degradation by the APC/C
Cdh1 
cell cycle regulator. This mainly occurs in the G1 phase before 
the start of DNA replication. USP1 is an important negative 
regulator  of  monoubiquitination  for  two  major  DNA  repair 
pathways (FA and TLS) that control genomic stability. Thus, 
proper dynamic control of USP1 levels throughout the cell cycle 
and during DNA damage may strongly impact how the cell 
deals with certain types of DNA lesions. To further validate this 
point,  experimental  evidence  has  suggested  that  higher  than 
normal levels of USP1 will inhibit the DNA damage–induced 
monoubiquitination of USP1 targets, such as FANCD2, FANCI, 
and  PCNA  (Huang  et  al.,  2006;  Oestergaard  et  al.,  2007), 
whereas the loss of USP1 has been shown to cause chromo-
somal instability and elevated perinatal lethality in mice (Kim   
et al., 2009).
Previous works by several groups have hinted at a new 
role for TLS that is linked to PCNA monoubiquitination outside 
of S phase. For example, Soria et al. (2009) has suggested that 
the TLS polymerase Pol- can be recruited to UV-induced DNA 
lesions in cells outside S phase, including cells permanently   
arrested in G1. Work in DT40 cells has shown that PCNA ubiqui-
tination may not be required to maintain normal fork progression 
on damaged DNA template but is essential for filling postrepli-
cative gaps (Edmunds et al., 2008). More recently, Ogi et al. 
(2010) has suggested that ubiquitinated PCNA is involved in the 
recruitment of the TLS polymerase Pol- to sites of UV lesions 
in the G1 phase. The function of ubiquitinated PCNA outside of 
S phase is tied to a gap-filling role or repair synthesis, which 
occurs downstream of NER. From our study, we believe that the 
cell prefers to maintain a low level of USP1 during G0/G1 to 
establish a permissive environment and allow for robust PCNA 
monoubiquitination if necessary (Fig. 4 F). Thus, in the absence 
of its negative regulator, PCNA can be rapidly activated after 
Degradation of USP1 permits UV-induced 
monoubiquitination of PCNA during G1
We then investigated the biological significance of USP1 degra-
dation in G1. One possibility is that the repair of UV-induced 
lesions in G1 requires robust PCNA monoubiquitination. In 
fact, PCNA monoubiquitination is involved in the recruitment 
of TLS polymerases to sites of UV damage for repair synthesis 
(Ogi et al., 2010). To test whether UV-induced DNA damage 
during G1 induces PCNA monoubiquitination, U2OS cells were 
synchronized in G1 by releasing them from a prometaphase 
block. 2 h after release, cells were either left untreated or UV   
irradiated and followed for up to 10 h. After UV damage, USP1 
levels decreased below the G1 levels, whereas in untreated cells, 
USP1 reaccumulated as they exited G1 and started DNA repli-
cation (Fig. 4 A). Accordingly, after UV damage, Cdh1 levels 
remained  elevated,  correlating  with  the  loss  of  USP1  and  a   
delay in S phase entry. Interestingly, robust monoubiquitination of 
PCNA already occurred by 2 h after UV damage and remained 
present for up to 10 h (Fig. 4 A). In contrast, detectable PCNA-
monoubiquitinated species only started to appear when non-
irradiated cells reached S phase. A strong UV-induced PCNA 
monoubiquitination response was also observed in T98G cells 
during G1 (Fig. 4 B). Interestingly, the monoubiquitination of 
FANCD2 and FANCI (FA pathway effector proteins) was not 
induced by UV damage in G1 (unpublished data). This is likely 
a result of low levels of UBE2T, the E2 conjugating enzyme for 
the FA pathway, in G1 that prevent activation of the FA pathway 
outside of S phase (unpublished data). We also noted that the 
DDR after UV damage is different in G1 versus S phase. For   
instance, UV irradiation targets the autocleavage and degradation 
of USP1 in S phase to promote PCNA monoubiquitination, as 
previously reported (Fig. 4 B; Huang et al., 2006). However, 
USP1 levels remain low and unchanged after UV damage in G1 
(Fig. 4 B), suggesting that the environment in G1 was already 
conducive for UV-mediated activation of PCNA monoubiqui-
tination. In addition, Cdh1 is degraded after UV damage in   
S phase cells (Liu et al., 2008) but not in G1. Also, the check-
point kinase Chk1 is not activated by phosphorylation after 
UV damage in G1.
We  also  found  that  the  mechanism  controlling  PCNA 
monoubiquitination in G1 is surprisingly similar to the Rad18-
dependent mechanism that governs its activation in S phase 
(Ogi et al., 2010). The knockdown of Rad18 resulted in the in-
hibition of UV-induced PCNA monoubiquitination during G1 
(Fig. 4 C). The monoubiquitination of PCNA is dependent on 
lysine 164 (unpublished data). Likewise, expression of stable 
degron  mutants  of  USP1  also  reduced  the  levels  of  PCNA 
monoubiquitination and the recruitment of the TLS polymerase 
Pol- to sites of UV lesions in G1 after UV damage (Fig. 4,   183 USP1 proteolysis by APC/C
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Figure 4.  UV-induced PCNA monoubiquitination during G1 requires prolonged degradation of USP1. (A) U2OS cells were synchronized in M phase 
with nocodazole (Noc) treatment and released for the indicated time points. Cells were also irradiated with 50 J/m
2 UV in G1 (2 h after release from   
nocodazole treatment). Samples were then analyzed by Western blotting. Cells from corresponding samples were pulsed with EdU (BrdU analogue) to label JCB • VOLUME 194 • NUMBER 2 • 2011   184
The internal deletion 295–342 amino acids of USP1 was generated   
by  a  site-directed  mutagenesis  kit  (Agilent  Technologies)  using  the   
primers  forward  5-CCAGTCATTGGAAGAGAAGTCTGCAACTAAGC-3  
and reverse 5-GCTTAGTTGCAGACTTCTCTTCCAATGACTGG-3. The   
following antibodies were used for Western blot analysis and/or immuno-
precipitation: WDR48/UAF1 (Evoquest; Invitrogen), USP28 (Bethyl Lab-
oratories, Inc.), Cdh1 (EMD), c-Myc (9E10; Santa Cruz Biotechnology, 
Inc.), HA (Covance), E2F1 (Bethyl Laboratories, Inc.), Emi1 (Invitrogen), 
PCNA  (PC10;  Santa  Cruz  Biotechnology,  Inc.),  tubulin  (Abcam),  Plk1   
(Abcam), actin (Abcam), cyclin A (EMD), Rad18 (Abcam), pChk1-317 
(Abcam), p21 (Abcam), and USP1, APC1, and Cdc27 (Bethyl Laboratories, 
Inc.). The GFP–Pol- expression construct was a gift from T. Ogi and   
A. Lehmann (University of Sussex, East Sussex, England, UK). Anti-USP1 
and FANCD2 antibodies were a gift from A. D’Andrea (Dana-Farber Can-
cer Institute, Boston, MA).
In vitro ubiquitination, DUB activity assay, and coimmunoprecipitation
USP1 constructs and Cdh1 were in vitro translated using the TNT T7–coupled 
wheat germ extract system (Promega) and TNT SP6–coupled reticulolysate 
system  (Promega),  respectively,  following  the  manufacturer’s  protocol.   
In vitro translation reactions were stopped using 1 mg/ml cycloheximide. 
Ubiquitination of in vitro–translated USP1 was performed at 30°C with 50 mM 
Tris, pH 7.6, 5 mM MgCl2, 2 mM ATP, 2.5 mg/ml ubiquitin, 1 µM   
ubiquitin aldehyde, 1.5 ng/µl UBE1, 25 ng/µl UBCH10, 5 ng/µl UBCH5 
(Boston Biochem), and 10 µM MG132 (EMD) in the presence or absence 
of in vitro–translated HA-Cdh1. UBCH10 and UBCH5 were chosen as the 
E2 enzyme pair to use for the in vitro ubiquitination assay after screening 
several E2 pairs to determine the best E2 combination to use (Fig. S2 A). 
Cdc6 was used as a positive control for an APC/C
Cdh1-specific ubiquitina-
tion substrate (Fig. S2 B), and methyl ubiquitin was used to confirm chain 
elongation for the in vitro ubiquitination assay (Fig. S2 C). UbVS DUB activ-
ity assay was performed according to Borodovsky et al. (2002) with several 
modifications. Cells were lysed for 1 h on ice with gentle tapping (250 mM 
Tris, 150 mM NaCl, 3 mM EDTA, and 0.5% NP-40). Supernatants from 
cell lysis were collected after a 10-min spin of 14,000 rpm at 4°C. Cell   
extracts and 50 µM HA-UbVS probe (Boston Biochem) were incubated at 
25°C for 1.5 h in DUB buffer (50 mM Tris, 50 mM NaCl, 10% glycerol, 
and 1 mM EDTA). Reactions were terminated with Laemmli buffer and 
boiled for Western blot analysis. Coimmunoprecipitation studies were per-
formed overnight at 4°C with the indicated antibodies according to the 
protocol previously described (Sims et al., 2007). In brief, cell lysis, anti-
body incubation, and bead washes were performed using low immunopre-
cipitation buffer (25 mM Tris, pH 7.5, 150 mM NaCl, 2 mM EDTA, and 
0.5% NP-40 with protease inhibitor cocktail [Roche]).
Induction of DNA damage and measurement of DNA synthesis
T98G and U2OS cells were treated and harvested between 50 and 80% 
visible cofluency. 254-nm UV-C irradiation was performed (Stratalinker 2400; 
Agilent Technologies) in the absence of DME media at 50 J/m
2. Recovery 
after UV damage was in complete medium for the times indicated. Replicat-
ing cells were detected using a flow cytometry assay kit (Click-iT EDU; Invit-
rogen) according to the manufacturer’s instructions. Flow cytometric data 
were acquired on a flow cytometer (LSR II; BD) using the FACS DiVa (BD) 
and Modfit LT softwares.
Online supplemental material
Fig. S1 shows the sequence alignment of the USP1 degron region. Fig. S2 
shows APC/C
Cdh1-dependent ubiquitination of USP1 using different E2 pairs 
UV damage to allow repair synthesis to occur downstream of 
the NER pathway. In contrast, expression of a nondegradable 
form of USP1 during G1 will lead to less monoubiquitinated 
PCNA and defective recruitment and repair of UV lesions by 
the TLS polymerases. The reliance on excision and gap filling–
based repair mechanisms becomes more crucial when cells are 
in quiescence or in the postmitotic phase because of the lack of 
available sister chromatid for homologous recombination repair 
(Hoeijmakers, 2001).
Materials and methods
Cell culture and cell cycle synchronization and cell images
T98G, HeLa, and U2OS cells were grown in DME with 10% FBS, 1%   
penicillin/streptomycin, and 1% glutamine. Cells were synchronized in 
G0/G1 by serum deprivation (0.05% FBS) for 72 h. After 72 h, cells were 
split, plated, and refed with normal cell culture media. Cells were synchro-
nized in M phase by incubating cells with 0.1 µg/ml nocodazole for 12–16 h. 
After 12–16 h, mitotic cells were shaken off, collected, and washed twice 
with 1× PBS and then plated with fresh media. To verify the cell cycle phase 
for  the  cell  synchronization  experiments,  cell  samples  were  stained  by 
propidium iodide (PI) according to the following staining procedure: cell 
pellets were washed and fixed in 70% ethanol overnight and stained with 
PI staining buffer (50 µg/ml PI and 10 µg/ml RNase in PBS). Flow cytome-
try analysis was performed using FACSCaliber and analyzed using Cell-
Quest  software  (BD)  and  Modfit  LT  (V3.1;  Verity  Software  House). 
Immunocytochemistry was performed according to protocol as previously 
described (Colnaghi et al., 2011). In brief, for detection of GFP–Pol- and 
Myc-USP1 proteins, U2OS cells were fixed in 100% methanol for 10 min, 
washed in PBS, blocked in 1% BSA in TBS–Tween 20, and incubated with 
mouse anti-GFP and rabbit anti-Myc antibodies (Santa Cruz Biotechnology, 
Inc.). Slides were mounted with Vectashield (Vector Laboratories) with DAPI 
and analyzed using 60× NA 1.42 objective lenses under oil immersion at 
26°C using Alexa Fluor 488 and 546 fluorochromes. Microscope images 
were captured using a DeltaVision system (Applied Precision) on a base 
microscope (IX71; Olympus) and a charged-coupled device camera (Cool-
Snap HQ2; Photometrics). Images were deconvolved, and maximum inten-
sity  Quick  projections  were  generated  using  SoftWorx  Suite  software 
(Applied Precision). The images were opened, sized, and placed into fig-
ures using ImageJ (National Institutes of Health) or Photoshop (7.0 Profes-
sional; Adobe) before transferring to Illustrator (CS3; Adobe).
Transfections, siRNA oligonucleotides, DNA constructs, and antibodies
Transfections with plasmids or siRNA oligonucleotides were performed using 
Fugene 6 (Roche) or Hiperfect (QIAGEN) reagent. The siRNA oligonucleotide 
sequences targeting human Cdh1 (5-AATGAGAAGTCTCCCAGTCAG-3) 
and human Rad18 (5-CCCGAGGTTAATGTAGTTGTT-3) were used. To 
generate human Myc-tagged USP1 truncation and deletion mutants, USP1 
cDNA was PCR amplified and subcloned into modified pcDNA3 plasmid 
(Invitrogen) containing the 5 sequence coding for 2× Myc epitope tag. 
Point mutations C90S or GG(670/671)AA were made by two-step PCR 
mutagenesis from the original USP1 template and verified by DNA se-
quencing as previously described (Huang et al., 2006). Truncation mutants 
were obtained by PCR amplification using specific 5 or 3 USP1 sequences. 
cells undergoing DNA synthesis. Samples were processed according to procedures outlined in the Materials and methods section and were analyzed by 
FACS. The data displayed as a bar graph are representative of two separate experiments. (B) T98G cells were synchronized in G0/G1 by serum depriva-
tion for 72 h, refed with fresh media, and collected at the indicated time points. Cells were either left untreated, UV exposed at 4 h after release from serum 
deprivation (G1 phase), or exposed after 21 h (early S phase). (C) U2OS cells were transfected with the indicated siRNAs, synchronized, released into 
G1 (3 h after nocodazole release), UV irradiated (50 J/m
2), and collected 3 h after UV exposure (6 h after release). (D) U2OS cells were transfected with 
either Myc-USP1 wild type (WT), 295–342 deletion (295–342 del), or GG670/671AA plus the 295–342 deletion mutant, synchronized in M phase (0 h),   
released into G1 (3 h), UV irradiated (3 h after nocodazole release), and then collected 3 h after UV exposure (6 h). (E) U2OS cells stably expressing 
GFP–Pol- were selected in G418 for 10 d before isolation of GFP-positive cells through a FACS sorter (MoFlo; Dako). Stable U2OS GFP–Pol-–expressing 
cells were transiently transfected with Myc-tagged GG670/671AA plus the 295–342 deletion mutant, synchronized in M phase with nocodazole, and 
released for 3 h into the G1 phase. The cells were then irradiated with 50 J/m
2 UV and fixed 2 h after UV exposure. Approximately 100 GFP-positive cells 
or GFP and Myc double-positive cells were analyzed. No Myc-expressing cells contained GFP–Pol- foci. A representative image of the cells analyzed is 
shown. GFP-positive nuclear foci formation was scored as the number of cells containing five or more foci. Bars, 20 µm. (F) A schematic representation 
of how USP1 is regulated by proteolysis in G1 versus S phase cells in the presence or absence of UV DNA damage. Black lines, active cells; gray lines, 
inactive cells; blue squiggly line, USP1 autocleavage site; Ub, ubiquitin.
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